Teladoc Health, Inc.
TDOC
$8.98
$0.0450.50%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -48.41M | -33.28M | -837.67M | -81.89M | -28.89M |
Total Depreciation and Amortization | 56.09M | 56.00M | 68.09M | 69.63M | 76.88M |
Total Amortization of Deferred Charges | 35.58M | 35.82M | 30.76M | 30.88M | 23.96M |
Total Other Non-Cash Items | 31.90M | 37.20M | 837.09M | 42.21M | 47.26M |
Change in Net Operating Assets | 10.74M | 14.44M | -9.59M | -51.91M | 10.87M |
Cash from Operations | 85.90M | 110.18M | 88.68M | 8.92M | 130.08M |
Capital Expenditure | -6.13M | -1.60M | -1.91M | -1.15M | -1.40M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -23.51M | -29.55M | -25.84M | -34.36M | -35.10M |
Cash from Investing | -29.64M | -31.15M | -27.75M | -35.51M | -36.51M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 2.06M | 957.00K | 3.83M | 1.65M | 1.11M |
Repurchase of Common Stock | -- | -176.00K | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 0.00 | -83.00K | -23.00K | 104.00K | -2.89M |
Cash from Financing | 2.06M | 698.00K | 3.81M | 1.75M | -1.78M |
Foreign Exchange rate Adjustments | -3.86M | 1.76M | -292.00K | -899.00K | 1.35M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 54.46M | 81.48M | 64.45M | -25.74M | 93.15M |